Hostname: page-component-5c6d5d7d68-xq9c7 Total loading time: 0 Render date: 2024-08-18T10:46:36.258Z Has data issue: false hasContentIssue false

Use of Bayes' Formula to Make a Genetic Risk Estimate

Published online by Cambridge University Press:  21 February 2012

Alan Stark
Affiliation:
Sydney IVF, Sydney, Australia.
Graeme Morgan*
Affiliation:
Sydney IVF, Sydney, Australia. morgangj@tpg.com.au
*
*ADDRESS FOR CORRESPONDENCE: Graeme Morgan, Sydney IVF, 321 Kent Street, Sydney, 2000, Australia.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Izabella and her partner sought pre-implantation genetic diagnosis (PGD) because Izabella had retinoblastoma due to a deletion in chromosome 13 and they want to have children not at genetic risk of retinoblastoma. Fortunately, Izabella's tumor was unilateral and was treated successfully and she is well. Izabella's chromosome abnormality is mosaic with 70% of lymphocytes having the deletion. This mosaicism may not be present in Izabella's ovaries. The couple went through PGD on two occasions and 13 embryos were tested. None had the deleted chromosome 13. IVF and PGD failed to produce a pregnancy. The couple wished to know what the experience provides as to the risk to their offspring: in particular, does it indicate a risk low enough to be acceptable if they go ahead with a natural pregnancy instead of another resort to PGD? Also, the couple did not want prenatal diagnosis. The situation therefore requires an estimate of the probability that an embryo will have the deletion. Counseling is problematic because there is no obvious way of selecting a prior probability from which to compute a Bayesian estimate of risk. Two solutions are offered, depending on the amount of information available about genes transmitted from the maternal grandparents.

Type
Articles
Copyright
Copyright © Cambridge University Press 2011